Product Overview
Semax is a synthetic hexapeptide supplied by PeptaCo for qualified laboratory research. It is a fragment of adrenocorticotropic hormone (ACTH) designed for enhanced nootropic research applications. Semax is widely referenced in neuroscience investigations, cognitive function studies, and neuroprotective peptide research.
Key Product Details
- Product Name: Semax
- Specification: As listed per catalog variant
- Product Form: Lyophilized powder
- Category: Neuro Research Peptides
- Peptide Length: 6 amino acids (ACTH fragment analog)
Chemical Identity
Semax is a modified fragment of ACTH(4-10) with the sequence Glu-His-Pro-Gly-Glu-Pro-Pro-Gly-Lys (extended with additional residues). Molecular Weight: ~985 Da. The peptide is designed for enhanced bioavailability in research settings. This listing covers Semax in multiple specifications (5mg, 10mg).
Research Context
Semax is extensively studied in neuroscience research for its effects on cognitive function, neuroprotection, and brain-derived neurotrophic factor (BDNF) modulation. It is commonly referenced in investigations of learning, memory formation, and peptide-mediated neural plasticity. PeptaCo supplies Semax in multiple specifications to support diverse research requirements.
Storage and Handling
Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.
Documentation and Quality
Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.
Important Notice
This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.
